4-Oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic acid(CAS: 56671-28-4)

4-Oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic acid (CAS: 56671-28-4) is subject to regulations such as the Globally Harmonized System (GHS) which includes health, environmental, and physical hazards. It is also regulated by REACH in the EU, which requires registration of substances above one tonne per year. FDA and EPA regulations may apply for specific uses and formulations in pharmaceuticals and pesticides.

In synthesis, alternatives to 4-Oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic acid include similar heterocyclic compounds such as 4-hydroxybenzofuran and 2-benzofuranacetic acid. These can be used as functional equivalents in various organic reactions, providing similar chemical properties which can be tailored to specific synthetic needs.

The market for 4-Oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic acid (CAS: 56671-28-4) is driven by its applications in pharmaceuticals, particularly as intermediates for drug synthesis. Research trends focus on its use in developing antiviral and anti-inflammatory drugs. Market demand is expected to grow with increasing pharmaceutical research activities.

Waste containing 4-Oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxylic acid (CAS: 56671-28-4) should be collected in appropriate containers, labeled with the chemical name and CAS number. It should be disposed of through professional waste disposal services that comply with local regulations. Incineration may be used if hazardous waste criteria are met, with precautions to manage potential emissions. Environmental protection measures should be followed to prevent soil and water contamination.